MedPath

Nextsource Biotechnology LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

FDA:3

Drug Approvals

Temozolomide

Approval Date
Apr 1, 2025
FDA

Sevoflurane

Approval Date
Feb 27, 2024
FDA

Gleostine

Approval Date
Jan 23, 2024
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.